JOSEPH R III HYDE
CIK 903352 · Chairman · last filed 2019-01-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$264.40M
Companies
3
Total Filings
144
Lifetime Open-Market Net
$24.61M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 15
144 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-04-05 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +3,188 | $15.6K | EDGAR |
| 2017-01-04 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +2,999 | $15.6K | EDGAR |
| 2017-01-03 | AZO | Grant (A) | +259 | $205.0K | EDGAR |
| 2016-10-27 | AZO | Exer (M) | +3,000 | $349.0K | EDGAR |
| 2016-10-17 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +7,716,049 | $6.25M | EDGAR |
| 2016-10-04 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +20,559 | $0 | EDGAR |
| 2016-08-01 | AZO | Gift (G) | −31,410 | $0 | EDGAR |
| 2016-07-05 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +28,409 | $0 | EDGAR |
| 2016-04-04 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +27,901 | $0 | EDGAR |
| 2016-01-05 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | +22,007 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.